title: How to manage melanoma in a psoriatic patient.
authors.forename: E
authors.initials: E
authors.lastname: Papadavid
authors.forename: A
authors.initials: A
authors.lastname: Psyrri
authors.forename: D
authors.initials: D
authors.lastname: Pectasides
authors.forename: A
authors.initials: A
authors.lastname: Katoulis
authors.forename: E
authors.initials: E
authors.lastname: Balamoti
authors.forename: M
authors.initials: M
authors.lastname: Dalamaga
authors.forename: N
authors.initials: N
authors.lastname: Stavrianeas
mesh_terms: D001327:Autoimmune Diseases / Q000139:chemically induced; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects*; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D011565:Psoriasis / Q000139:chemically induced* / Q000150:complications / Q000276:immunology; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy*
chemical_list: D007155:Immunologic Factors; D016898:Interferon-alpha